News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Oxygen Therapy Device for Wound Healing from Ogenix Corporation Gets FDA Warning Letter


4/5/2012 8:32:51 AM

Ogenix has received a warning letter from the U.S. Food and Drug Administration related to its Epiflo oxygen therapy medical device for wound healing. The FDA’s warning letter details six specific violations uncovered during an inspection of the Florida-based company’s manufacturing facility in Beachwood, Ohio. Most of the violations deal with issues that involve documentation and record keeping. For example, the FDA cites Ogenix for failing to include in its analysis risks involving strength and durability of the Epiflo. Some field complaints cited the breakage of locks on the device, but Ogenix’s analysis didn’t reflect these risks, according to the letter.

Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES